Status:
COMPLETED
Evaluation of the Effect of Triamcinolone at Different Doses on LIA During TKA
Lead Sponsor:
Peking University Third Hospital
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
50-85 years
Phase:
PHASE4
Brief Summary
To evaluate the efficacy and safety of different doses of triamcinolone for local infiltration analgesia during total knee replacement
Detailed Description
Participants were enrolled according to protocol requirements. Patients who meet all inclusion criteria and do not have any exclusion criteria will be considered for inclusion in the study and will pr...
Eligibility Criteria
Inclusion
- age in the range of 50 to 85 years old
- patients with knee osteoarthritis requiring primary unilateral total knee replacement
- the body mass index in the range of 18 to 36 kg/m2
- possess the physical status I-III of American Society of Anesthesiologists
- the patient and his family members agree and sign the informed consent
Exclusion
- Non-osteoarthritis (rheumatoid arthritis, traumatic arthritis, septicemic arthritis, etc.)
- History of knee surgery or knee injury, such as high tibial osteotomy, meniscus repair, ligament reconstruction, etc
- Flexion deformity ≥30°, internal and external varus deformity ≥15°
- People allergic to the drugs used in this study
- Patients who had used glucocorticoids within 3 months before surgery
Key Trial Info
Start Date :
April 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05997238
Start Date
April 25 2023
End Date
May 1 2024
Last Update
June 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100181